Objective: The goals of this study were to investigate the risk factors and outcomes of community-onset CDI in the older adults.
Methods: The epidemiology and outcomes of community-onset CDI were evaluated in elderly patients aged >60 years hospitalized at 5 acute-care hospitals in south-east Michigan between January 2005 and December 2008. CDI was defined as a patient with diarrhea and a positive stool C. Diff toxin enzyme immunoassay. CDI was classified using the CDC surveillance definitions: a) Hospital-onset CDI (HO-CDI), CDI onset ≥48 hrs after hospitalization; b) Community-onset CDI (CO-CDI), CDI onset < 48 hours after hospital admission; c) CO-healthcare-facility associated CDI (CO-HCFA), CDI that occurred < 4 weeks after discharge from a HCF; d) CO-community associated CDI (CO-CA), CDI onset >12 weeks after discharge from a HCF; e) CO-indeterminate CDI (CO-CI), CDI that did not fit any of the above criteria for an exposure setting. Variables within the study included demographics, laboratory findings, co-morbidities, and death due to CDI within 30 days.
Results: The cohort comprised 428 older adults with CDI. 153 CO-CDI cases were compared to 275 HO-CDI. Mean age for the two groups were 77 vs 76 years (p=0.09). Females were more likely to develop CO-CDI as compared to HO-CDI (65% vs 58%,p=0.2). History of prior CDI was independently associated with greater risk of CO-CDI (OR=2.5, CI 1.1-5.5). Although the median McCabe score at admission favored CO-CDI, 2 [IQR-3-2] vs 1 [IQR-1-1] for HO-CDI (p=0.3), mortality due to CDI in CO-CDI was higher 27 (18%) versus HO-CDI 34 (12%) (p=0.15).
Classification of CDI |
Mean Age±SD |
Death due to CDI |
HO-HCFA |
76±9.9 |
12.4% |
CO-HCFA |
75±8.6 |
6.7% |
CO-CA |
79.4±9.9 |
28.4% |
CO-CI |
75±7.8 |
10.7% |
Conclusions: In our cohort of older adults, a prior episode of CDI was associated with 2.5 times higher risk of CO-CDI. Overall mortality due to CDI was higher in patients with CO-CDI, and greatest in patients with CO-CA CDI. The reasons for adverse outcomes seen in patients with CO-CA are unclear at this point but may be related to older age, lack of early recognition of CDI, or a more virulent community strain of C. difficile. Close monitoring and aggressive clinical management should be considered in patients with CO-CA CDI.